Skip to content

Your must-see guide to RSNA 2025

Explore
  • There are no suggestions because the search field is empty.
  • There are no suggestions because the search field is empty.
featured-image

Press Release

RapidAI Extends the Reach of Deep Clinical AI with Five New FDA Clearances

SAN MATEO, Calif. — November 25, 2025 — RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced the U.S. Food and Drug Administration (FDA) clearance of five new imaging modules: Rapid DeltaFuse™, Rapid LMVO, Rapid MLS, Rapid OH, and Rapid Aortic for measurement. Together, these clearances mark a significant expansion of the Rapid Enterprise™ Platform, reinforcing RapidAI’s identity as the only platform purpose-built to bring deep clinical intelligence, seamless workflow integration, and secure IT infrastructure to hospitals worldwide.
featured-image

Press Release

RapidAI Earns FDA Clearance for Rapid Aortic, Bringing AI-Driven Aortic Measurements and Surveillance to Care Teams

SAN MATEO, Calif. — November 18, 2025 — RapidAI, the pioneer of deep clinical AI and global leader in enterprise imaging, today announced U.S. Food and Drug Administration (FDA) clearance of Aortic Management, part of the Rapid Aortic product, a comprehensive deep clinical AI solution designed to transform the acute assessment and longitudinal management of aortic disease.
featured-image

Press Release

RapidAI and Health Holdings Company Partner to Bring Deep Clinical AI To Saudi Arabia

San Mateo, Calif. and Riyadh, Saudi Arabia — November 11, 2025 — RapidAI, the pioneer of Deep Clinical AI and global leader in intelligent imaging and workflow integration, today announced a strategic partnership and co-development with Saudi Health Holdings Company (HHC), the largest healthcare provider in the Middle East. Through this collaboration, RapidAI will serve as HHC’s enterprise provider of deep clinical AI across its 20 health clusters network of hospitals and clinics, supporting multiple disease states in neurology, cardiology, vascular, oncology, orthopedic and beyond.
featured-image

Press Release

Baptist Health Strengthens Statewide Stroke Care Network with RapidAI’s Deep Clinical AI

LITTLE ROCK, Ark. — October 29, 2025 — In recognition of World Stroke Day, Baptist Health, Arkansas’ most comprehensive health care organization, is highlighting how its partnership with RapidAI, the global leader in deep clinical AI and workflow integration, is helping clinicians across the state deliver faster, more connected care for stroke patients.
featured-image

Press Release

Lumina 3D by RapidAI Named to TIME’s List of the Best Inventions of 2025

San Mateo, Calif. — October 9, 2025 // RapidAI, the pioneer of deep clinical AI and the global leader in image-based decision support and workflow efficiencies, today announced that its Lumina 3D™ built on the Rapid Enterprise™ Platform has been named to TIME’s List of the Best Inventions of 2025, honoring 300 extraordinary innovations changing the way we live, work, and care for one another.
featured-image

Press Release

Tift Regional Medical Center Advances Stroke Care with RapidAI’s Deep Clinical AI

TIFTON, GA – August 18, 2025 – In a move to advance stroke care and accelerate critical decision-making, Tift Regional Medical Center (TRMC) has implemented RapidAI’s deep clinical AI platform, bringing faster insights and improved coordination to stroke response teams. The technology is now live across TRMC’s stroke program and is already helping clinicians deliver more timely and informed care. RapidAI, whose platform has helped shape the modern stroke treatment window, uses clinically validated AI to analyze brain images in real time. The solution helps physicians identify blood clots, brain bleeds, and changes in brain tissue to support urgent treatment decisions. “When it comes to stroke, every minute matters,” said Jeff Robbins, Director of Neurodiagnostics/Telehealth. “RapidAI gives our physicians fast, accurate data that helps clarify stroke severity and support collaborative decisions in the most critical moments. That level of insight can truly make a difference in patient outcomes.” The introduction of RapidAI is part of TRMC’s broader effort to integrate the most advanced technology into care pathways. The platform supports stroke care by:
featured-image

Press Release

New Study Finds RapidAI Significantly Outperforms Viz.ai in Detecting Medium Vessel Occlusions in Stroke Patients

RapidAI detects 33% more MeVOs than Viz.ai, with new real-world data presented at ESOC highlighting superior accuracy and deeper clinical insights
featured-image

Press Release

RapidAI Reveals Superiority Over Competition in LVO Detection – 33% More Cases Identified Than Leading Competitor

DUEL study reveals RapidAI’s unmatched accuracy (98% sensitivity vs Viz.ai 74% sensitivity) in stroke detection, alongside additional transformative hemorrhagic validation data and 17 new studies SAN MATEO, Calif. – February 5, 2025 – The numbers speak for themselves, RapidAI’s deep clinical AI is delivering results where competitors are falling short. New data from the largest head-to-head study to date proves RapidAI’s LVO detection outperforms Viz.ai by a staggering 33%, detecting far more stroke cases and reducing the risk of missed diagnoses.
featured-image

Press Release

RapidAI Secures FDA 510(k) Clearance for Groundbreaking AI 3D Head and Neck CTA Imaging: Lumina 3D™

RapidAI continues to pioneer AI advances by revolutionizing 3D imaging with no-click, AI-powered reconstruction. SAN MATEO, Calif. – February 3, 2025 – RapidAI, the global leader in AI-driven medical imaging analysis and coordinated care, has received FDA 510(k) clearance for Lumina 3D™ by RapidAI—an industry-first, automated 3D imaging reconstruction solution designed to replace manual workflows with an AI-powered approach based on the latest groundbreaking AI technology advances.
1 2 3